Sinclair Pharma PLC (LON:SPH)‘s stock had its “buy” rating reissued by analysts at N+1 Singer in a report released on Wednesday.

SPH has been the subject of several other reports. Stifel Nicolaus restated a “buy” rating and set a GBX 49 ($0.64) price target on shares of Sinclair Pharma PLC in a research report on Thursday, September 1st. Peel Hunt restated a “buy” rating and set a GBX 66 ($0.86) price target on shares of Sinclair Pharma PLC in a research report on Tuesday, July 19th. Jefferies Group cut their price target on shares of Sinclair Pharma PLC from GBX 60 ($0.78) to GBX 55 ($0.72) and set a “buy” rating for the company in a research report on Wednesday, June 15th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of Sinclair Pharma PLC in a research report on Thursday, September 15th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Sinclair Pharma PLC has a consensus rating of “Buy” and an average target price of GBX 57 ($0.74).

Shares of Sinclair Pharma PLC (LON:SPH) remained flat at GBX 27.00 on Wednesday. The company’s stock had a trading volume of 4,838,870 shares. The firm’s market capitalization is GBX 134.19 million. Sinclair Pharma PLC has a 1-year low of GBX 26.25 and a 1-year high of GBX 61.33. The firm’s 50 day moving average price is GBX 29.71 and its 200-day moving average price is GBX 32.60.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/sinclair-pharma-plc-sph-stock-rating-reaffirmed-by-n1-singer.html

About Sinclair Pharma PLC

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.

Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.